Search results
Results from the Health.Zone Content Network
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...
The AstraZeneca vaccine is stable at higher temperatures than the Pfizer-BioNTech vaccine, able to be refrigerated between 35°F (2°C) and 46°F (8°C) rather than stored in an ultra-cold freezer ...
In the United Kingdom, 138,000 people had received the Pfizer-BioNTech COVID‑19 vaccine Comirnaty by 16 December, during the first week of the UK vaccination programme. On 18 December 2020, the US FDA granted an EUA for mRNA-1273, the Moderna vaccine. Vaccine manufacturers are awaiting full approvals to name their vaccines.
The short-term side effects of the authorized COVID-19 vaccines are similar. The side effects typically start within a day or two of getting the vaccine and may include: pain, redness, or swelling ...
Takeaway. Dimensions/Getty Images. “Fully vaccinated,” at least in the context of COVID-19, means you have received all the vaccine doses recommended for someone in your demographic. Getting ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The COVID-19 mRNA vaccines from Moderna and Pfizer–BioNTech have efficacy rates of 90 to 95 percent [citation needed]. Prior mRNA, drug trials on pathogens other than COVID-19 were not effective and had to be abandoned in the early phases of trials. The reason for the efficacy of the new mRNA vaccines is not clear.
2 min read. Feb. 18, 2023 – A new study shows the Pfizer vaccine is safe and highly effective against COVID-19 in children as young as 6 months old. A three-dose series of the Pfizer COVID-19 ...